Share Price and Basic Stock Data
Last Updated: November 8, 2025, 9:20 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Garodia Chemical Ltd, operating in the Trading & Distributors sector, reported a share price of ₹7.65 and a market capitalization of ₹5.51 Cr. The company has faced significant challenges, as evidenced by its sales figures, which consistently stood at ₹0.00 across all quarters from June 2022 to June 2025. This lack of revenue generation raises concerns about the company’s operational viability and market positioning. The company’s expenses, however, have fluctuated, with total expenses recorded at ₹0.06 Cr in FY 2023 and rising to ₹0.21 Cr in FY 2025. The absence of sales alongside rising operational costs indicates a troubling trend, suggesting operational inefficiencies that need urgent attention. Furthermore, the company has not reported any other income during this period, contributing to its negative financial trajectory.
Profitability and Efficiency Metrics
Garodia Chemical Ltd’s profitability metrics reveal a worrying trend, as the company has reported consistent net losses. Net profit figures for FY 2023 were recorded at ₹-0.06 Cr, worsening to ₹-0.21 Cr by FY 2025. Operating profit also reflected this decline, with figures consistently in the negative, from ₹-0.10 Cr in FY 2022 to ₹-0.21 Cr in FY 2025. The operating profit margin (OPM) remains unreported, but the negative operating profit indicates a severe inability to manage costs relative to any potential revenue. The return on capital employed (ROCE) stood at a staggering -170.80% in FY 2025, significantly below typical sector benchmarks, which usually hover around positive values for healthy companies. This alarming figure underscores the inefficiencies in utilizing capital and raises flags about the company’s operational management.
Balance Sheet Strength and Financial Ratios
The balance sheet of Garodia Chemical Ltd reflects significant financial distress, with total liabilities amounting to ₹0.14 Cr against total assets of ₹0.14 Cr as of FY 2025. The company has reported negative reserves, declining to ₹-11.90 Cr, indicating that liabilities exceed assets, a concerning sign for stakeholders. Borrowings have increased slightly from ₹4.34 Cr in FY 2023 to ₹4.82 Cr in FY 2025, highlighting a reliance on debt financing amidst operational challenges. The price-to-book value ratio stood at -2.04x, which is significantly below the expected range for the sector, typically above 1. This indicates that the market values the company less than its book value, raising questions about investor confidence and long-term sustainability. The current ratio of 4.36 suggests a strong liquidity position, but it is overshadowed by the company’s ongoing losses.
Shareholding Pattern and Investor Confidence
Garodia Chemical Ltd’s shareholding structure reveals a stable promoter holding of 51.79%, indicating a strong control by the founders. The government holds 10.42%, while public shareholders constitute 37.79%. The number of shareholders remained relatively stable at 7,647 from June 2023 to June 2025, which shows some level of investor retention despite the company’s financial difficulties. However, the absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) suggests a lack of external validation and support, which can negatively impact stock performance and market perception. The stability in promoter holdings may provide some reassurance, but the continuous operational losses and lack of revenue generation could deter new investment, leading to potential volatility in shareholder sentiment.
Outlook, Risks, and Final Insight
Looking ahead, Garodia Chemical Ltd faces significant challenges that could hinder recovery and growth. The persistent lack of revenue generation, coupled with rising operational costs, poses a major risk to sustainability. The company’s reliance on debt financing, as indicated by the increasing borrowings, further complicates its financial stability. However, the strong promoter holding offers a potential avenue for strategic changes or restructuring that could enhance operational efficiency. The risks associated with continued losses and negative investor sentiment remain critical concerns. Should the company successfully implement a turnaround strategy focusing on cost management and revenue generation, it may regain investor confidence and stabilize its financial standing. Conversely, failure to address these issues could lead to more severe financial distress or even insolvency.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Garodia Chemical Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minal Industries Ltd | 70.0 Cr. | 3.65 | 5.59/3.20 | 41.7 | 2.77 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Mitshi India Ltd | 13.5 Cr. | 15.3 | 18.6/13.0 | 449 | 3.09 | 0.00 % | 0.36 % | 0.37 % | 10.0 |
| Modella Woollens Ltd | 6.50 Cr. | 71.4 | 74.2/52.5 | 4.95 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 95.5 Cr. | 46.6 | 49.8/10.2 | 94.6 | 15.0 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
| MRP Agro Ltd | 110 Cr. | 98.6 | 174/84.4 | 15.5 | 30.6 | 0.00 % | 39.2 % | 30.3 % | 10.0 |
| Industry Average | 10,457.45 Cr | 169.73 | 138.32 | 117.71 | 0.25% | 15.44% | 8.88% | 7.74 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.01 | 0.01 | 0.01 | 0.02 | 0.05 | 0.01 | 0.04 | 0.03 | 0.01 | 0.02 | 0.05 | 0.12 | 0.06 |
| Operating Profit | -0.01 | -0.01 | -0.01 | -0.02 | -0.05 | -0.01 | -0.04 | -0.03 | -0.01 | -0.02 | -0.05 | -0.12 | -0.06 |
| OPM % | |||||||||||||
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.01 | -0.01 | -0.01 | -0.02 | -0.05 | -0.01 | -0.04 | -0.03 | -0.01 | -0.02 | -0.05 | -0.12 | -0.06 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -0.01 | -0.01 | -0.01 | -0.02 | -0.05 | -0.01 | -0.04 | -0.03 | -0.01 | -0.02 | -0.05 | -0.12 | -0.06 |
| EPS in Rs | -0.01 | -0.01 | -0.01 | -0.03 | -0.07 | -0.01 | -0.06 | -0.04 | -0.01 | -0.03 | -0.07 | -0.17 | -0.08 |
Last Updated: August 19, 2025, 2:50 pm
Below is a detailed analysis of the quarterly data for Garodia Chemical Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Expenses, as of Jun 2025, the value is 0.06 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.12 Cr. (Mar 2025) to 0.06 Cr., marking a decrease of 0.06 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.06 Cr.. The value appears strong and on an upward trend. It has increased from -0.12 Cr. (Mar 2025) to -0.06 Cr., marking an increase of 0.06 Cr..
- For OPM %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.06 Cr.. The value appears strong and on an upward trend. It has increased from -0.12 Cr. (Mar 2025) to -0.06 Cr., marking an increase of 0.06 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is -0.06 Cr.. The value appears strong and on an upward trend. It has increased from -0.12 Cr. (Mar 2025) to -0.06 Cr., marking an increase of 0.06 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.08. The value appears strong and on an upward trend. It has increased from -0.17 (Mar 2025) to -0.08, marking an increase of 0.09.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:17 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 | -0.00 | 0.00 |
| Expenses | 0.06 | 0.07 | 0.21 | 0.11 | 0.13 | 0.20 | 0.26 | 0.18 | 0.09 | 0.06 | 0.13 | 0.21 | 0.25 |
| Operating Profit | -0.06 | -0.07 | -0.21 | -0.11 | -0.13 | -0.20 | -0.26 | -0.18 | -0.10 | -0.06 | -0.13 | -0.21 | -0.25 |
| OPM % | |||||||||||||
| Other Income | -0.00 | -1.67 | 6.14 | -0.00 | 3.58 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
| Interest | -0.00 | -0.00 | -0.00 | -0.00 | 0.02 | -0.00 | 0.42 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
| Depreciation | 0.12 | 0.11 | 0.11 | 0.11 | 0.11 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
| Profit before tax | -0.18 | -1.85 | 5.82 | -0.22 | 3.32 | -0.20 | -0.68 | -0.18 | -0.10 | -0.06 | -0.13 | -0.21 | -0.25 |
| Tax % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | |
| Net Profit | -0.18 | -1.85 | 5.81 | -0.22 | 3.32 | -0.20 | -0.68 | -0.18 | -0.10 | -0.06 | -0.13 | -0.21 | -0.25 |
| EPS in Rs | -0.25 | -2.57 | 8.07 | -0.31 | 4.61 | -0.28 | -0.94 | -0.25 | -0.14 | -0.08 | -0.18 | -0.29 | -0.35 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -927.78% | 414.05% | -103.79% | 1609.09% | -106.02% | -240.00% | 73.53% | 44.44% | 40.00% | -116.67% | -61.54% |
| Change in YoY Net Profit Growth (%) | 0.00% | 1341.83% | -517.84% | 1712.88% | -1715.12% | -133.98% | 313.53% | -29.08% | -4.44% | -156.67% | 55.13% |
Garodia Chemical Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 11% |
| 3 Years: | % |
| TTM: | -178% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 3% |
| 3 Years: | 3% |
| 1 Year: | 3% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 3:31 pm
Balance Sheet
Last Updated: October 10, 2025, 4:07 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 | 7.20 |
| Reserves | -17.41 | -19.26 | -13.44 | -13.66 | -10.34 | -10.54 | -11.22 | -11.40 | -11.50 | -11.56 | -11.69 | -11.90 |
| Borrowings | 6.03 | 8.37 | 7.22 | 7.32 | 3.80 | 3.43 | 4.08 | 4.18 | 4.31 | 4.34 | 4.50 | 4.82 |
| Other Liabilities | 6.64 | 6.03 | 0.87 | 0.48 | 0.01 | 0.02 | 0.11 | 0.13 | 0.10 | 0.08 | 0.10 | 0.02 |
| Total Liabilities | 2.46 | 2.34 | 1.85 | 1.34 | 0.67 | 0.11 | 0.17 | 0.11 | 0.11 | 0.06 | 0.11 | 0.14 |
| Fixed Assets | 1.59 | 1.48 | 1.37 | 1.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.87 | 0.86 | 0.48 | 0.08 | 0.67 | 0.11 | 0.17 | 0.11 | 0.11 | 0.06 | 0.11 | 0.14 |
| Total Assets | 2.46 | 2.34 | 1.85 | 1.34 | 0.67 | 0.11 | 0.17 | 0.11 | 0.11 | 0.06 | 0.11 | 0.14 |
Below is a detailed analysis of the balance sheet data for Garodia Chemical Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 7.20 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 7.20 Cr..
- For Reserves, as of Mar 2025, the value is -11.90 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -11.69 Cr. (Mar 2024) to -11.90 Cr., marking a decline of 0.21 Cr..
- For Borrowings, as of Mar 2025, the value is 4.82 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 4.50 Cr. (Mar 2024) to 4.82 Cr., marking an increase of 0.32 Cr..
- For Other Liabilities, as of Mar 2025, the value is 0.02 Cr.. The value appears to be improving (decreasing). It has decreased from 0.10 Cr. (Mar 2024) to 0.02 Cr., marking a decrease of 0.08 Cr..
- For Total Liabilities, as of Mar 2025, the value is 0.14 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.11 Cr. (Mar 2024) to 0.14 Cr., marking an increase of 0.03 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 0.14 Cr.. The value appears strong and on an upward trend. It has increased from 0.11 Cr. (Mar 2024) to 0.14 Cr., marking an increase of 0.03 Cr..
- For Total Assets, as of Mar 2025, the value is 0.14 Cr.. The value appears strong and on an upward trend. It has increased from 0.11 Cr. (Mar 2024) to 0.14 Cr., marking an increase of 0.03 Cr..
However, the Borrowings (4.82 Cr.) are higher than the Reserves (-11.90 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -6.09 | -8.44 | -7.43 | -7.43 | -3.93 | -3.63 | -4.34 | -4.36 | -4.41 | -4.40 | -4.63 | -5.03 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | |||||||||||
| Inventory Days | 0.00 | |||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0.00 | |||||||||||
| Working Capital Days | -1,825.00 | |||||||||||
| ROCE % | -23.91% | 40.79% | -53.33% | -346.67% | -900.00% | -323.08% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.29 | -0.18 | -0.08 | -0.14 | -0.24 |
| Diluted EPS (Rs.) | -0.29 | -0.18 | -0.08 | -0.14 | -0.24 |
| Cash EPS (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -6.52 | -6.24 | -6.05 | -5.97 | -5.83 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -6.52 | -6.24 | -6.05 | -5.97 | -5.83 |
| PBDIT / Share (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| PBIT / Share (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| PBT / Share (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| Net Profit / Share (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| Return on Capital Employeed (%) | -170.80 | -853.17 | 342.31 | -1091.55 | 1173.56 |
| Return On Assets (%) | -148.88 | -203.41 | -56.42 | -96.16 | -164.79 |
| Long Term Debt / Equity (X) | -1.03 | -1.00 | -0.99 | -1.00 | -0.99 |
| Total Debt / Equity (X) | -1.03 | -1.00 | -0.99 | -1.00 | -0.99 |
| Current Ratio (X) | 4.36 | 0.06 | 0.36 | 0.46 | 0.37 |
| Quick Ratio (X) | 4.36 | 0.06 | 0.36 | 0.46 | 0.37 |
| Enterprise Value (Cr.) | 14.36 | 11.41 | 11.18 | 8.12 | 8.01 |
| EV / EBITDA (X) | -69.15 | -87.07 | -186.40 | -79.12 | -45.66 |
| Price / BV (X) | -2.04 | -1.54 | -1.57 | -0.88 | -0.91 |
| EarningsYield | -0.02 | -0.01 | -0.01 | -0.02 | -0.04 |
After reviewing the key financial ratios for Garodia Chemical Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.29. This value is below the healthy minimum of 5. It has decreased from -0.18 (Mar 24) to -0.29, marking a decrease of 0.11.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.29. This value is below the healthy minimum of 5. It has decreased from -0.18 (Mar 24) to -0.29, marking a decrease of 0.11.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 3. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -6.52. It has decreased from -6.24 (Mar 24) to -6.52, marking a decrease of 0.28.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -6.52. It has decreased from -6.24 (Mar 24) to -6.52, marking a decrease of 0.28.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 2. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 0. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 0. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 2. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For Return on Capital Employeed (%), as of Mar 25, the value is -170.80. This value is below the healthy minimum of 10. It has increased from -853.17 (Mar 24) to -170.80, marking an increase of 682.37.
- For Return On Assets (%), as of Mar 25, the value is -148.88. This value is below the healthy minimum of 5. It has increased from -203.41 (Mar 24) to -148.88, marking an increase of 54.53.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -1.03. This value is below the healthy minimum of 0.2. It has decreased from -1.00 (Mar 24) to -1.03, marking a decrease of 0.03.
- For Total Debt / Equity (X), as of Mar 25, the value is -1.03. This value is within the healthy range. It has decreased from -1.00 (Mar 24) to -1.03, marking a decrease of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 4.36. This value exceeds the healthy maximum of 3. It has increased from 0.06 (Mar 24) to 4.36, marking an increase of 4.30.
- For Quick Ratio (X), as of Mar 25, the value is 4.36. This value exceeds the healthy maximum of 2. It has increased from 0.06 (Mar 24) to 4.36, marking an increase of 4.30.
- For Enterprise Value (Cr.), as of Mar 25, the value is 14.36. It has increased from 11.41 (Mar 24) to 14.36, marking an increase of 2.95.
- For EV / EBITDA (X), as of Mar 25, the value is -69.15. This value is below the healthy minimum of 5. It has increased from -87.07 (Mar 24) to -69.15, marking an increase of 17.92.
- For Price / BV (X), as of Mar 25, the value is -2.04. This value is below the healthy minimum of 1. It has decreased from -1.54 (Mar 24) to -2.04, marking a decrease of 0.50.
- For EarningsYield, as of Mar 25, the value is -0.02. This value is below the healthy minimum of 5. It has decreased from -0.01 (Mar 24) to -0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Garodia Chemical Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -170.8% (Industry Average ROCE: 15.44%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 8.88%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.36
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 138.32)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -1.03
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | 149/156, Garodia Shopping Centre, Garodia Nagar, Mumbai Maharashtra 400077 | gclshares@gmail.com www.gchem.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ravindra Subhash Salunkhe | Chairperson & Managing Director |
| Mr. Vikram Ravindra Sabnis | Additional Non Exe.Non Ind.Director |
| Mr. Suraj Kodak | Addnl.Non Exe.Independent Director |
| Ms. Megha Brahmankar | Addnl.Non Exe.Independent Director |
| Mrs. Bhagyashri Nilesh Devrale | Addnl.Non Exe.Independent Director |
FAQ
What is the intrinsic value of Garodia Chemical Ltd?
Garodia Chemical Ltd's intrinsic value (as of 08 November 2025) is 11.99 which is 57.76% higher the current market price of 7.60, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 5.47 Cr. market cap, FY2025-2026 high/low of 13.4/5.71, reserves of ₹-11.90 Cr, and liabilities of 0.14 Cr.
What is the Market Cap of Garodia Chemical Ltd?
The Market Cap of Garodia Chemical Ltd is 5.47 Cr..
What is the current Stock Price of Garodia Chemical Ltd as on 08 November 2025?
The current stock price of Garodia Chemical Ltd as on 08 November 2025 is 7.60.
What is the High / Low of Garodia Chemical Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Garodia Chemical Ltd stocks is 13.4/5.71.
What is the Stock P/E of Garodia Chemical Ltd?
The Stock P/E of Garodia Chemical Ltd is .
What is the Book Value of Garodia Chemical Ltd?
The Book Value of Garodia Chemical Ltd is 6.53.
What is the Dividend Yield of Garodia Chemical Ltd?
The Dividend Yield of Garodia Chemical Ltd is 0.00 %.
What is the ROCE of Garodia Chemical Ltd?
The ROCE of Garodia Chemical Ltd is 323 %.
What is the ROE of Garodia Chemical Ltd?
The ROE of Garodia Chemical Ltd is %.
What is the Face Value of Garodia Chemical Ltd?
The Face Value of Garodia Chemical Ltd is 10.0.